Untargeted Metabolomic Study of Patients with Wet Age-Related Macular Degeneration in Aqueous Humor
Qingquan Wei,Xianghong Tu,Qinghua Qiu,Li Wang
DOI: https://doi.org/10.2147/cia.s475920
IF: 3.829
2024-09-27
Clinical Interventions in Aging
Abstract:Qingquan Wei, Xianghong Tu, Qinghua Qiu, Li Wang Department of Ophthalmology, Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China Correspondence: Qinghua Qiu; Li Wang, Department of Ophthalmology, Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, 1111 Xianxia West Road, Shanghai, 200336, People's Republic of China, Email ; Purpose: The objective of this study was to ascertain metabolic biomarkers and investigate the metabolic alterations associated with aqueous humor (AH) in wet age-related macular degeneration (AMD). Methods: AH samples were collected from a total of 20 participants, including 10 individuals diagnosed with wet AMD and 10 individuals undergoing cataract surgery, serving as the control group. Metabolomics analysis was performed using liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify and quantify metabolites. Results: A total of 155 metabolites were identified in the AH samples. Among them, 10 metabolites emerged as potential biomarkers capable of differentiating patients with wet AMD from the control group. In the AH of wet AMD patients, there was increased expression of Cardiolipin (CL) (72:5), Diglyceride (DG) (18:3_18:2), DG (36:5e) and Triglyceride (TG) (24:7), while the expression of Ceramides (Cer) (d32:0), Cer (d34:0), Cer (d36:0), Monogalactosyldiacylglycerol (MGDG) (16:1_18:3), Sphingosine (SPH) (d18:0) and TG (16:0_10:4_16:0) was down regulated. Conclusion: Through metabolomics analysis of AH, this study successfully uncovered valuable metabolic biomarkers linked to wet AMD. These findings contribute to a more comprehensive understanding of the pathogenesis of wet AMD and offer potential avenues for the development of innovative treatment strategies for this condition. Keywords: metabolomic, wet age-related macular degeneration, aqueous humor Age-related macular degeneration (AMD) is a common cause of irreversible vision loss in individuals over the age of 50 and constitutes a significant concern in global public health. 1,2 AMD can be clinically classified into two forms: dry AMD and wet AMD. Wet AMD, accounting for 90% of blindness cases caused by AMD, is characterized by choroidal neovascularization (CNV). 3,4 Although the diagnosis of wet AMD is conclusive, there is still controversy surrounding the etiology and pathophysiological mechanisms of the condition. Metabolomics is a research field involving the identification and quantification of small molecules (metabolites) in biological samples and has been utilized to study metabolic alterations associated with various diseases, offering insights into their underlying mechanisms. 5,6 Metabolomic analysis of aqueous humor (AH) has exhibited potential in revealing metabolic changes related to eye diseases. 7,8 Studies have indicated that myopic patients have significantly different metabolic profiles in AH compared to healthy controls. 9 Specifically, increased concentrations of 27 important metabolites were found in myopic patients. 10 These metabolites may provide valuable information about metabolic changes that occur in the eye during the development and progression of myopia. In glaucoma—a complex neurodegenerative disease affecting the optic nerve-metabolomic analysis of AH has revealed dysregulation of metabolites related to osmoprotection, neuroprotection, and amino acid metabolism. 11 These findings suggest that metabolomics might play a role in understanding the pathophysiology of glaucoma and in identifying biomarkers for disease progression. Additionally, in diabetic retinopathy (DR), a common complication of diabetes affecting the retina, metabolomics research on AH has identified differential metabolites. 12 These metabolites might be associated with the metabolic dysregulation and vascular dysfunction observed in DR. However, the application of metabolomics in investigating wet AMD remains limited, and further research is needed to elucidate specific metabolic changes associated with this condition. Therefore, the goal of this study is to perform a comparative analysis between wet AMD patients and a control group to identify unique metabolic alterations. Furthermore, the study aims to identify potential biomarkers among these differentially regulated metabolites, which could help to better understand the pathophysiology of wet AMD and aid in the development of diagnostic and therapeutic strategies. The study enrolled 20 subjects from December 1, 2021, to March 1, 2023. All study protocols adhered to the ethical principles outlined in the Declaration of Helsinki. The institutional Research Ethics Committee of the Tong Ren Hospital affiliated with the Shanghai J -Abstract Truncated-
geriatrics & gerontology,gerontology